Intuitive Surgical Inc (ISRG)
547.87
-2.75
(-0.50%)
USD |
NASDAQ |
Nov 22, 16:00
548.60
+0.73
(+0.13%)
After-Hours: 20:00
Intuitive Surgical Cash from Investing (Quarterly): -1.413B for Sept. 30, 2024
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | -1.413B |
| June 30, 2024 | -467.10M |
| March 31, 2024 | -128.50M |
| December 31, 2023 | -1.044B |
| September 30, 2023 | -446.60M |
| June 30, 2023 | 557.60M |
| March 31, 2023 | 573.10M |
| December 31, 2022 | 574.80M |
| September 30, 2022 | 544.50M |
| June 30, 2022 | 466.20M |
| March 31, 2022 | -214.70M |
| December 31, 2021 | -641.00M |
| September 30, 2021 | -838.80M |
| June 30, 2021 | -384.70M |
| March 31, 2021 | -597.00M |
| December 31, 2020 | -334.30M |
| September 30, 2020 | -1.026B |
| June 30, 2020 | 536.70M |
| March 31, 2020 | -117.10M |
| December 31, 2019 | -406.20M |
| September 30, 2019 | -216.60M |
| June 30, 2019 | -222.70M |
| March 31, 2019 | -308.90M |
| December 31, 2018 | -486.30M |
| September 30, 2018 | -572.60M |
| Date | Value |
|---|---|
| June 30, 2018 | -44.30M |
| March 31, 2018 | 53.60M |
| December 31, 2017 | -315.80M |
| September 30, 2017 | -260.00M |
| June 30, 2017 | -353.80M |
| March 31, 2017 | 1.308B |
| December 31, 2016 | -309.00M |
| September 30, 2016 | -541.30M |
| June 30, 2016 | -237.20M |
| March 31, 2016 | -191.90M |
| December 31, 2015 | -413.10M |
| September 30, 2015 | -338.80M |
| June 30, 2015 | -9.90M |
| March 31, 2015 | -87.70M |
| December 31, 2014 | -203.50M |
| September 30, 2014 | -258.70M |
| June 30, 2014 | 513.60M |
| March 31, 2014 | -205.30M |
| December 31, 2013 | -63.20M |
| September 30, 2013 | 613.20M |
| June 30, 2013 | 57.00M |
| March 31, 2013 | -348.00M |
| December 31, 2012 | -142.70M |
| September 30, 2012 | -177.90M |
| June 30, 2012 | -116.90M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-1.413B
Minimum
Sep 2024
574.80M
Maximum
Dec 2022
-240.31M
Average
-359.50M
Median
Cash from Investing (Quarterly) Benchmarks
| Abbott Laboratories | -594.00M |
| Becton Dickinson & Co | -3.937B |
| Masimo Corp | -13.50M |
| PROCEPT BioRobotics Corp | -0.246M |
| Perspective Therapeutics Inc | -29.74M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 706.50M |
| Cash from Financing (Quarterly) | 98.20M |
| Free Cash Flow | 586.00M |
| Free Cash Flow Per Share (Quarterly) | 1.264 |
| Free Cash Flow to Equity (Quarterly) | 458.60M |
| Free Cash Flow to Firm (Quarterly) | 458.60M |
| Free Cash Flow Yield | 0.30% |